Clinical Trials

Sponsor: Beat Childhood Cancer

Sponsor Study ID: BCC016

Study Title: Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma

NCT Number: NCT04696029

Phase: II

Protocol Type: Treatment

Age Group: Children

Disease Sites: Brain and Nervous System

Study Objectives:

For more information about the trial above please contact the study team:

Principal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu.
Study Coordinator, Jake Rodriguez, at rodrijos@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina

Study Documents
(MUSC NetID required for document access)